DE602005020014D1 - Kristallines mycophenolat-natrium - Google Patents

Kristallines mycophenolat-natrium

Info

Publication number
DE602005020014D1
DE602005020014D1 DE602005020014T DE602005020014T DE602005020014D1 DE 602005020014 D1 DE602005020014 D1 DE 602005020014D1 DE 602005020014 T DE602005020014 T DE 602005020014T DE 602005020014 T DE602005020014 T DE 602005020014T DE 602005020014 D1 DE602005020014 D1 DE 602005020014D1
Authority
DE
Germany
Prior art keywords
mycophenolate sodium
crystalline mycophenolate
crystalline
sodium
processes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602005020014T
Other languages
English (en)
Inventor
Sandor Molnar
Csaba Szabo
Tivadar Tamas
Janos Hajko
Adrienne Kovacsne-Mezei
Judith Aronhime
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Teva Pharmaceutical Works PLC
Original Assignee
Teva Pharmaceutical Works PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharmaceutical Works PLC filed Critical Teva Pharmaceutical Works PLC
Publication of DE602005020014D1 publication Critical patent/DE602005020014D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/83—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
    • C07D307/88—Benzo [c] furans; Hydrogenated benzo [c] furans with one oxygen atom directly attached in position 1 or 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Transplantation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Furan Compounds (AREA)
DE602005020014T 2004-07-20 2005-07-20 Kristallines mycophenolat-natrium Active DE602005020014D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US58990904P 2004-07-20 2004-07-20
US63184904P 2004-11-29 2004-11-29
PCT/US2005/025816 WO2006012385A2 (en) 2004-07-20 2005-07-20 Crystalline mycophenolate sodium

Publications (1)

Publication Number Publication Date
DE602005020014D1 true DE602005020014D1 (de) 2010-04-29

Family

ID=35385154

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005020014T Active DE602005020014D1 (de) 2004-07-20 2005-07-20 Kristallines mycophenolat-natrium

Country Status (10)

Country Link
US (4) US7439373B2 (de)
EP (2) EP1699773A2 (de)
JP (2) JP2008506783A (de)
CN (2) CN101052631A (de)
AT (1) ATE461182T1 (de)
CA (2) CA2573781A1 (de)
DE (1) DE602005020014D1 (de)
ES (1) ES2340184T3 (de)
TW (2) TW200611692A (de)
WO (2) WO2006012379A2 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2032712T3 (da) * 2006-06-29 2010-05-25 Ivax Pharmaceuticals Sro Regulering af syremetabolitproduktion
US20080176937A1 (en) * 2007-01-23 2008-07-24 Apotex Fermentation Inc. Novel crystalline mycophenolate sodium polymorph and processes to manufacture same
US20080182998A1 (en) * 2007-01-25 2008-07-31 Apotex Fermentation Inc. Novel crystalline mycophenolate sodium polymorph and processes to manufacture same
BRPI0803097A2 (pt) * 2007-04-11 2011-11-08 Teva Gyogyszergyar ... método para redução do nìvel de impurezas na fermentação do ácido micofenólico
US20100010082A1 (en) * 2008-07-09 2010-01-14 Aspreva International Ltd. Formulations for treating eye disorders
WO2010041269A1 (en) * 2008-09-10 2010-04-15 Ipca Laboratories Limited Process for preparation of mycophenolic acid, its salt and ester derivatives
CN102464639A (zh) * 2010-11-16 2012-05-23 北京京卫信康医药科技发展有限公司 麦考酚酸钠的新晶型及其制备方法
CN103923044A (zh) * 2010-11-16 2014-07-16 北京京卫信康医药科技发展有限公司 麦考酚酸钠的新晶型及其制备方法
CN103880800A (zh) * 2010-11-16 2014-06-25 北京京卫信康医药科技发展有限公司 麦考酚酸钠的新晶型及其制备方法
CN103880799A (zh) * 2010-11-16 2014-06-25 北京京卫信康医药科技发展有限公司 麦考酚酸钠的新晶型及其制备方法
AR099354A1 (es) 2013-11-15 2016-07-20 Akebia Therapeutics Inc Formas sólidas de ácido {[5-(3-clorofenil)-3-hidroxipiridin-2-carbonil]amino}acético, composiciones, y sus usos
CN106350550B (zh) * 2016-11-28 2019-05-07 无锡福祈制药有限公司 一种自麦考酚酸菌株制备麦考酚钠的方法
CN106866594A (zh) * 2017-02-17 2017-06-20 上海华源医药科技发展有限公司 适用于麦考酚钠工业化生产的优化工艺
RU2723255C2 (ru) * 2018-11-14 2020-06-09 Общество с ограниченной ответственностью "Изварино Фарма" Экструдат с микофенолятом натрия для получения пероральной твердой лекарственной формы
CN110922371B (zh) * 2019-12-27 2020-08-11 广东蓝宝制药有限公司 一种m2晶型麦考酚钠的制备方法
CN112645912B (zh) * 2020-12-27 2022-05-13 广东蓝宝制药有限公司 一种高纯度m2晶型麦考酚钠的制备方法
CN114478452B (zh) * 2022-02-22 2024-02-06 广东蓝宝制药有限公司 一种麦考酚钠的制备方法

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1157099A (en) 1966-09-27 1969-07-02 Ici Ltd Fermentation Process
GB1158387A (en) 1967-06-13 1969-07-16 Ici Ltd Procedure for Isolation of Mycophenolic Acid
ZA684959B (en) 1967-11-22 1969-05-22 Lilly Co Eli Agents and methods for inhibiting the growth of malignant tumor cells in warm-blooded mammals
US4452891A (en) * 1980-09-08 1984-06-05 Ajinomoto Company Incorporated Method for production of mycophenolic acid by fermentation
US4861776A (en) * 1987-01-30 1989-08-29 Syntex (U.S.A) Inc. Heterocyclic aminoalkyl esters of mycophenolic acid and derivatives thereof, compositions and use
US4753935A (en) 1987-01-30 1988-06-28 Syntex (U.S.A.) Inc. Morpholinoethylesters of mycophenolic acid and pharmaceutical compositions
US4748173A (en) 1987-01-30 1988-05-31 Syntex (U.S.A.) Inc. Heterocyclic aminoalkyl esters of mycophenolic acid and derivatives thereof and pharmaceutical compositions
US5247083A (en) 1992-07-10 1993-09-21 Syntex (U.S.A.) Inc. Direct esterification of mycophenolic acid
US5455045A (en) * 1993-05-13 1995-10-03 Syntex (U.S.A.) Inc. High dose formulations
DK0724581T3 (da) * 1993-09-15 1999-08-02 Syntex Inc Krystallinsk vandfri mycophenolatmofetil og intravenøs formulering deraf
JP3844491B2 (ja) 1993-10-01 2006-11-15 シンテックス（ユー・エス・エイ）インコーポレイテッド ミコフェノール酸モフェチル高用量経口用懸濁剤
ID18663A (id) 1996-04-12 1998-04-30 Novartis Ag Komposisi farmasi berlapis enterik
GB9812413D0 (en) * 1998-06-10 1998-08-05 Glaxo Group Ltd Compound and its use
IN188985B (de) * 1998-12-09 2002-11-30 Biocon Ltd
HUP9903226A2 (en) 1999-09-23 2002-08-28 Gyogyszerki Process for producing mycophenolic acid and derivatives thereof
AU2000233225A1 (en) 2000-02-29 2001-09-12 Biocon India Limited Manufacture and purification of mycophenolic acid
CZ292123B6 (cs) 2001-06-08 2003-08-13 Ivax Pharmaceuticals S.R.O. Způsob přípravy mykofenolátu mofetilu
GB0124953D0 (en) * 2001-10-17 2001-12-05 Novartis Ag Organic Compounds
CA2468435C (en) 2002-08-29 2008-02-19 Biocon Limited Process for the production of an immunosuppressant
GB0301259D0 (en) 2003-01-20 2003-02-19 Novartis Ag Organic compounds
TWI221414B (en) * 2003-02-21 2004-10-01 Chunghwa Chemical Synthesis & Method of making mycophenolate mofetil using transesterification
GB0307553D0 (en) 2003-04-01 2003-05-07 Novartis Ag Organic compounds

Also Published As

Publication number Publication date
WO2006012385A3 (en) 2006-06-22
CN101014584A (zh) 2007-08-08
US20080097096A1 (en) 2008-04-24
EP1908756A1 (de) 2008-04-09
ES2340184T3 (es) 2010-05-31
CN101052631A (zh) 2007-10-10
TW200611692A (en) 2006-04-16
WO2006012379A8 (en) 2006-04-20
US20060069150A1 (en) 2006-03-30
US7439373B2 (en) 2008-10-21
JP2008506784A (ja) 2008-03-06
ATE461182T1 (de) 2010-04-15
US20080103317A1 (en) 2008-05-01
TW200615272A (en) 2006-05-16
EP1699773A2 (de) 2006-09-13
TWI322147B (en) 2010-03-21
CA2573784A1 (en) 2006-02-02
JP2008506783A (ja) 2008-03-06
US20060069152A1 (en) 2006-03-30
WO2006012379A3 (en) 2006-06-22
WO2006012385A2 (en) 2006-02-02
WO2006012379A2 (en) 2006-02-02
CA2573781A1 (en) 2006-02-02

Similar Documents

Publication Publication Date Title
ATE461182T1 (de) Kristallines mycophenolat-natrium
DE602004000470D1 (de) Fotomaske
DE602005004477D1 (de) Softrouter
NO20053748D0 (no) Pyrrolopyridazinderivater.
DE602005016150D1 (de) Flügelzellen-nockenwellenversteller
ATE506362T1 (de) 1-aza-bicycloä3.3.1ünonane
FR2893200B1 (fr) Alternateur.
DE102004052020B8 (de) Druckformmanipulator
DE502005006071D1 (de) Flügelzellen-nockenwellenversteller
DE502005000334D1 (de) Spannvorrichtung
DE602006017660D1 (de) Maskenrohlinge
DE602004021069D1 (de) Nockenwellenverstellereinrichtung
DE60331395D1 (de) CO2 Inkubator
DE602004004284D1 (de) Datum-korrigierer
DE502005011057D1 (de) Laseranordnung
ITMI20051313A1 (it) Tutore per ginocchio
DE60327250D1 (de) Modifizierte bace
ES1057865Y (es) Desatascador de desagues.
ES1056623Y (es) Flexometro perfeccionado.
ES1057444Y (es) Flexometro.
NO20035165D0 (no) Fremgangsmåte for effektiv meldingsutveksling
ITRM20030174V0 (it) Incubatrice neonatale insonorizzata.
ITLC20040002A1 (it) P.p.0
UA6551S (uk) Інкубатор для яєць
NO20035507L (no) Koblingsdel for bardun.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition